Dear Colleagues! This is Asrar Qureshi’s Blog Post #1258 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here.
Preamble
This post is based on insights taken from Harvard Business School Working Knowledge article by Ashley V. Whillans and Rachel Kim Rackza. Link at the end.
When Incentives Redefine Priorities: A Pharma Industry Perspective on Bonuses, Performance, and Life
The pharmaceutical industry is built on precision, compliance, and performance.
From sales targets to regulatory milestones, from product launches to market share growth, everything is measured, tracked, and rewarded. And rightly so.
In a high-stakes industry where outcomes impact both business and patient lives, performance matters. But beneath this structured system lies a quieter, less examined reality: the way we reward performance in pharma is also shaping how professionals live their lives.
The Invisible Influence of Incentives
In pharma, incentives are deeply embedded in the system.
- Sales representatives are rewarded for achieving targets
- Managers are evaluated on team performance
- Leadership is measured against strategic outcomes
Bonuses, commissions, and performance-linked rewards are designed to drive productivity, encourage competitiveness, and align individual effort with organizational goals. And they work.
But they also do something else. They subtly influence how professionals allocate time, which relationships they prioritize, and what they consider important.
The Reality on the Ground
Consider the daily life of a pharmaceutical sales professional. Early morning hospital visits, long hours meeting doctors, evening calls with key opinion leaders, and travel across cities and regions.
Now add performance incentives into the equation. Every interaction becomes an opportunity, a metric, and a step toward a target.
Over time, work relationships become economically valuable, and personal relationships become secondary. A family dinner may be postponed, a social gathering may be skipped, and/or a weekend may become a working day.
Not because professionals do not value their personal lives, but because the system rewards something else.
From Professional Commitment to Personal Trade-Off
The pharmaceutical industry often celebrates dedication.
- “He is always available.”
- “She goes the extra mile.”
- “They never miss a target.”
But what does this dedication cost?
Research suggests that performance-based incentives can lead professionals to spend less time with family, prioritize work interactions over personal ones, and experience higher work-life conflict.
In pharma, where roles are already demanding, this effect is amplified.
The Culture of “Always On”
The industry has, over time, developed an “always-on” culture.
- Doctors are available at unpredictable times
- Market opportunities do not follow office hours
- Competitive pressure is constant
When incentives are layered onto this environment, professionals begin to feel, “If I am not working, I am falling behind.”
This leads to extended working hours, reduced rest, and continuous mental engagement. The line between work and personal life begins to disappear.
The Hidden Cost: Burnout and Attrition
The consequences of this system are becoming increasingly visible.
Across the pharmaceutical industry, organizations are facing rising burnout levels, increased attrition, and difficulty retaining experienced talent.
Professionals may perform well in the short term. But over time, stress accumulates, motivation declines, and engagement weakens.
This creates a paradox. The same incentive systems that drive performance can also undermine sustainability.
A Deeper Issue: What Are We Really Rewarding?
In pharma, incentives often reward volume of prescriptions, sales growth, and market expansion.
But what they rarely reward is sustainable work practices, team collaboration, and personal well-being.
This creates a narrow definition of success. Professionals begin to equate success with numbers, targets, and rankings.
While aspects like health, relationships, and balance are pushed to the margins.
The Ethical Dimension
The pharmaceutical industry operates under strong ethical frameworks. Patient safety, regulatory compliance, and scientific integrity are usually built into the business model.
Yet, when it comes to internal systems like incentives, the ethical dimension is often overlooked. If an incentive system encourages overwork, creates stress, and disrupts personal lives, then it raises an important question: Are we aligning our internal practices with the values we claim externally?
Rethinking Incentives in Pharma
The solution is not to eliminate incentives; it is to redesign them.
Broaden Performance Metrics. Instead of focusing solely on sales outcomes, include customer relationship quality, compliance adherence, team collaboration, and long-term impact.
Incorporate Well-Being Indicators. Organizations can monitor workload balance, track burnout indicators, and include well-being in performance discussions. This signals that health is as important as performance.
Reward Sustainable Behavior. Recognize professionals who maintain consistent performance without burnout, support team members, and demonstrate ethical practices. This shifts the culture from “More is better” to “Sustainable is better”.
Leadership Become Role Models. Leaders in pharma must set boundaries, respect personal time and avoid glorifying overwork. Because culture is shaped not by policies, but by behavior.
The Competitive Advantage of Balance
There is a common fear that if we reduce pressure, performance will decline. But evidence suggests otherwise.
Organizations that prioritize well-being often see higher engagement, better retention, and stronger long-term performance.
In pharma, where relationships and trust are critical, sustainable professionals are more effective than exhausted ones.
A Personal Reflection for Pharma Professionals
For individuals in the industry, this insight is equally important.
Ask yourself:
- What is driving my choices?
- Am I working for performance, or being driven by incentives?
- What am I sacrificing, and is it worth it?
Because over time, daily decisions become habits, habits become lifestyle, and lifestyle becomes identity.
The Bigger Question for the Industry
The pharmaceutical industry is at a crossroads.It is evolving in more sophisticated technology, more stringent regulations, and more competitive market dynamics.
But one area requires urgent attention: human sustainability. If the industry wants to attract and retain the best talent, it must move from ‘performance at any cost’ to ‘performance with sustainability’.
Sum Up
The core insight is simple, but powerful. Incentives do not just shape performance. They shape priorities; and ultimately, lives.
In an industry that exists to improve human health, this insight carries special significance. Because healthy organizations require healthy people. And healthy people need systems that support, not undermine, their well-being.
The pharmaceutical industry has always been driven by innovation. It now needs to innovate in how it defines success, designs incentives, and supports its people. Because in the end, the true measure of success is not just what we achieve, but how we achieve it, and at what cost.
Concluded.
Disclaimers: Pictures in these blogs are taken from free resources at Pexels, Pixabay, Unsplash, and Google. Credit is given where available. If a copyright claim is lodged, we shall remove the picture with appropriate regrets.
For most blogs, I research from several sources which are open to public. Their links are mentioned under references. There is no intent to infringe upon anyone’s copyrights. If, any claim is lodged, it will be acknowledged and duly recognized immediately.
Reference:
https://www.library.hbs.edu/working-knowledge/how-bonuses-get-employees-to-choose-work-over-family
